Plasma 17OH-progesterone concentrations in newborn infants

Area of Science:

• Neonatal endocrinology
• Biochemical markers in pediatrics

Background:

• 17-hydroxyprogesterone (17-OHP) levels in newborns are influenced by placental transfer and endogenous production.
• Rapid changes in 17-OHP concentrations occur in the neonatal period, necessitating precise timing for accurate assessment.

Purpose of the Study:

• To establish reference ranges for plasma 17-hydroxyprogesterone in normal newborns.
• To differentiate between normal neonatal 17-OHP levels and those indicative of congenital adrenal hyperplasia (CAH).

Main Methods:

• Plasma samples were collected from 60 normal infants aged 3-36 hours and 70 normal infants aged 2-7 days.
• Plasma 17-hydroxyprogesterone concentrations were measured using established biochemical assays.
• Levels were compared between normal infants and infants with untreated CAH.

Main Results:

• Mean plasma 17-hydroxyprogesterone levels decreased significantly from 3 to 36 hours of age in normal infants.
• Normal infants aged 2-7 days had a mean plasma 17-OHP of 3.5 nmol/1 (1.2 ng/ml).
• Infants with untreated CAH exhibited markedly elevated plasma 17-OHP concentrations compared to normal infants.

Conclusions:

• Plasma 17-hydroxyprogesterone measurement is a valuable diagnostic tool for neonatal endocrine disorders.
• Accurate interpretation of 17-OHP levels requires careful consideration of infant age and sample collection timing.
• This assay aids in the evaluation of disorders of sexual differentiation and electrolyte imbalance in newborns.